Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling

Experimental Hematology

Volumn 40, Issue 5, 2012, Pages 418-427

  Su, Wenxia ^a   Meng, Fankai ^a   Huang, Lifang ^a   Zheng, Miao ^a   Liu, Wenli ^a   Sun, Hanying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD34 ANTIGEN; CYCLOPAMINE; NEUTRALIZING ANTIBODY; SONIC HEDGEHOG PROTEIN; STEM CELL FACTOR RECEPTOR; WNT3A PROTEIN;

ADULT; APOPTOSIS; ARTICLE; BCL 2 GENE; BLAST CELL CRISIS; CELL EXPANSION; CELL GROWTH; CELL SURVIVAL; CHEMOSENSITIVITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE TARGETING; GLI1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; M PHASE CELL CYCLE CHECKPOINT; MALE; ONCOGENE C MYC; P21 GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL;

ADULT; APOPTOSIS; BETA CATENIN; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; G2 PHASE; HEDGEHOG PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, ACCELERATED PHASE; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VERATRUM ALKALOIDS; WNT3A PROTEIN;

ERINACEIDAE;

EID: 84862780640     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.003     Document Type: Article

References (38)

1. Welscher P.T., Zuniga A., Kuijper S., et al. Progression of vertebrate limb development through SHH-mediated counteraction of GLI3. Science 2002, 298:827-830.
2. Crompton T., Outram S.V., Hager-Theodorides A.L. Sonic hedgehog signalling in T-cell development and activation. Nat Rev Immunol 2007, 7:726-735.
3. Sengupta A., Banerjee D., Chandra S., et al. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007, 21:949-955.
4. Bhardwaj G., Murdoch B., Wu D., et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001, 2:172-180.
5. Favaro R., Valotta M., Ferri A.L.M., et al. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 2009, 12:U1248-U1262.
6. Barnes E.A., Heidtman K.J., Donoghue D.J. Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene 2005, 24:902-915.
7. Xie J.W., Murone M., Luoh S.M., et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998, 391:90-92.
8. Watkins D.N., Berman D.M., Burkholder S.G., Wang B.L., Beachy P.A., Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317.
9. Berman D.M., Karhadkar S.S., Maitra A., et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
10. Karhadkar S.S., Bova G.S., Abdallah N., et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707-712.
11. Dierks C., Grbic J., Zirlik K., et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007, 13:944-951.
12. Yauch R.L., Gould S.E., Scales S.J., et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:U406-U461.
13. Peacock C.D., Wang Q.J., Gesell G.S., et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A 2007, 104:4048-4053.
14. Li C.W., Heidt D.G., Dalerba P., et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
15. Jorgensen H.G., Holyoakel T.L. Characterization of cancer stem cells in chronic myeloid leukaemia. Biochem Soc Trans 2007, 35:1347-1351.
16. Neering S.J., Bushnell T., Sozer S., et al. Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 2007, 110:2578-2585.
17. Sirard C., Lapidot T., Vormoor J., et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 1996, 87:1539-1548.
18. Wang J.C., Lapidot T., Cashman J.D., et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 1998, 91:2406-2414.
19. Hu Y., Chen Y., Douglas L., Li S. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 2009, 23:109-116.
20. Jamieson C.H.M., Ailles L.E., Dylla S.J., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004, 351:657-667.
21. Jamieson C.H.M., Ailles L.E., Muijtjens M., et al. The role of beta-catenin in chronic myelogenous leukemic progenitor expansion. Blood 2003, 102. 570a-570a.
22. Khan N.I., Bradstock K.F., Bendall L.J. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 2007, 138:338-348.
23. Yin D.D., Fan F.Y., Hu X.B., et al. Notch signaling inhibits the growth of the human chronic myeloid leukemia cell line K562. Leuk Res 2009, 33:109-114.
24. Chen J.K., Taipale J., Cooper M.K., Beachy P.A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Gene Dev 2002, 16:2743-2748.
25. Chen J.K., Taipale J., Young K.E., Maiti T., Beachy P.A. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci U S A 2002, 99:14071-14076.
26. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
27. Wei W., Chua M.S., Grepper S., So S.K. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 2009, 8:76.
28. Sanchez P., Hernandez A.M., Stecca B., et al. Inhibition of prostate cancer proliferation by interference with SONICHEDGEHOG-GLI1 signaling. Proc Natl Acad Sci U S A 2004, 101:12561-12566.
29. Copland M., Hamilton A., Elrick L.J., et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 2006, 107:4532-4539.
30. Jorgensen H.G., Allan E.K., Jordanides N.E., Mountford J.C., Holyoake T.L. Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. Blood 2007, 109:4016-4019.
31. Lu D.S., Zhao Y.D., Tawatao R., et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2004, 101:3118-3123.
32. Khan N.I., Bradstock K.F., Bendall L.J. The Wnt pathway modulates expression of growth and survival genes in acute lymphoblastic leukemia cells. Blood 2006, 108. 524a-524a.
33. Wang Y.Z., Krivtsov A.V., Sinha A.U., et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010, 327:1650-1653.
34. Zhao C., Blum J., Chen A., et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12:528-541.
35. Li X., Deng W., Lobo-Ruppert S.M., Ruppert J.M. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 2007, 26:4489-4498.
36. Meng L., Hsu J.K., Tsai R.Y.L. GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. Oncogene 2011, 30:1716-1726.
37. Ohta M., Tateishi K., Kanai F., et al. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 2005, 65:10822-10829.
38. van de Wetering M., Sancho E., Verweij C., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.